Skip to main content
. 2021 Apr 3;9(4):380. doi: 10.3390/biomedicines9040380
AB Alcian blue
API active pharmaceutical ingredient
BPyV bovine polyomavirus
CAM chorioallantoic membrane
CD cluster of differentiation
CHUV Centre hospitalier universitaire Vaudois
DMEM Dulbecco’s modified Eagle medium
DMSO dimethyl sulfoxide
EBV Epstein-Barr virus
ECACC European Collection of Authenticated Cell Cultures
ECM extracellular matrix
EDTA ethylenediaminetetraacetic acid
EOPCB end of production cell bank
ESC embryonic stem cell
ESWT extracorporeal shock wave therapy
FBS fetal bovine serum
FIRDI Food Industry Research and Development Institute
FPC fetal progenitor cells
GLP good laboratory practices
GMP good manufacturing practices
HA hyaluronic acid
HAV hepatitis A virus
HBV hepatitis B virus
HBoV human bocavirus
hCMV human cytomegalovirus
HCV hepatitis C virus
HE hematoxylin-eosin
hFPT human fetal progenitor tenocytes
HHV human herpes virus
HIV human immunodeficiency virus
HPV human papilloma virus
HTLV human T-cell lymphotropic virus
ISO International Organization for Standardization
KIPyV KI polyomavirus
MCB master cell bank
MoA mechanism of action
MRI magnetic resonance imaging
MSC mesenchymal stem cell
NO nitric oxide
NSAID non-steroidal anti-inflammatory drug
OECD Organization for Economic Cooperation and Development
PBS phosphate-buffered saline
PCB parental cell bank
PDT population doubling time
PDV population doubling value
PEMF pulsed electromagnetic field therapy
PRP platelet-rich plasma
PTFE polytetrafluoroethylene
RH relative humidity
SAID steroidal anti-inflammatory drug
SD standard deviation
SR Picrosirius red
SV40 simian virus 40
TEM transmission electron microscopy
UK United Kingdom
USA United States of America
WCB working cell bank
WUPyV WU polyomavirus